AVDL

Avadel Pharmaceuticals PLC

Price

return (12m)

p/e

-7,496.71

p/bv

21.37

DIVIDEND YIELD

0.00%

AVDL price

Avadel Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AVDL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AVDL

Valuation

P/E

-7,496.71

Sector 1.09

Industry -1.78

P/BV

21.37

Sector 1.86

Industry 1.35

P/Revenue (PSR)

8.45

Sector 1.55

Industry 2.25

EV/EBITDA

560.75

Sector -47.62

Industry -42.38

EV/EBIT

812.75

Sector -27.52

Industry -45.58

P/EBITDA

207.21

Sector -32.64

Industry -23.10

P/EBIT

324.93

Sector -43.02

Industry -27.18

P/Total Assets

10.52

Sector 0.87

Industry 0.82

P/Net Current Assets

29.56

Sector -27.09

Industry -72.46

P/Working Capital

19.13

Sector -4.05

Industry -2.10

EPS

0.00

Sector -0.70

Industry -1.11

BVPS

1.01

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

94.91%

Sector 49.36%

Industry 50.48%

EBITDA Margin

4.62%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

3.19%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

1.82%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-0.11%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.39

Sector 0.13

Industry 0.06

Profitability

ROE

-0.29%

Sector -24.32%

Industry -33.33%

ROA

-0.14%

Sector -24.41%

Industry -45.72%

ROIC

3.82%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.76

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-25.58

Sector -4.96

Industry -8.98

Net Debt / EBIT

-37.08

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.93

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.49

Sector 0.46

Industry 0.52

Liabilities/Assets

0.51

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-67.51%

Sector -

Industry -

Fundamentals AVDL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AVDL Avadel Pharmaceuticals PLC	$0.00	-100.00%	0.00%	-7,496.71	21.37	-0.29%	-0.11%
LLY Eli Lilly and Compay	$1,142.35	51.23%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.38	-6.23%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.03	29.66%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.69	-30.85%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.73	-12.06%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-17.58%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.78	-95.06%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$139.78	16.35%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$653.75	38.92%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$429.56	8.26%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.66	9.40%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AVDL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Avadel Pharmaceuticals

Avadel Pharmaceuticals PLC

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

1996

Time since IPO - 30 years

50

Employees

Avadel Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $2.10 billion, with shareholders equity totaling $98.22 million.

The company employs approximately 50 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Avadel Pharmaceuticals PLC reported $248.52 million in revenue, generating net income of $-280.00 Thousand.

Key financial metrics include a P/E ratio of -7,496.71, a price-to-book (P/B) ratio of 21.37, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AVDL.

Market cap

$2.10 billion

Net worth

$98.22 million

$98,220,000.00

Assets

$199.45 million

$199,450,000.00

Total Shares Outstanding

97.00 million

97,000,000

Average Daily Trading Volume

$1.51 million

$1,511,982.04

Sector

Health

Industry

Pharmaceutical Products

AVDL

AVDL revenue and profits

Financial Results AVDL

DRAG THE FRAME TO SEE MORE DATA

AVDL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35